Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ABCIXIMAB Cause Haemorrhagic transformation stroke? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Haemorrhagic transformation stroke have been filed in association with ABCIXIMAB. This represents 4.4% of all adverse event reports for ABCIXIMAB.

14
Reports of Haemorrhagic transformation stroke with ABCIXIMAB
4.4%
of all ABCIXIMAB reports
12
Deaths
3
Hospitalizations

How Dangerous Is Haemorrhagic transformation stroke From ABCIXIMAB?

Of the 14 reports, 12 (85.7%) resulted in death, 3 (21.4%) required hospitalization, and 10 (71.4%) were considered life-threatening.

Is Haemorrhagic transformation stroke Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ABCIXIMAB. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does ABCIXIMAB Cause?

Thrombocytopenia (71) Off label use (35) Haemorrhage (29) Incorrect route of drug administration (28) Haemorrhage intracranial (23) Anaemia (22) Drug interaction (17) Product use issue (17) Vascular stent thrombosis (17) Cerebral haemorrhage (15)

What Other Drugs Cause Haemorrhagic transformation stroke?

ALTEPLASE (496) RIVAROXABAN (257) ASPIRIN (213) DABIGATRAN ETEXILATE (113) CLOPIDOGREL BISULFATE (85) TENECTEPLASE (49) HEPARIN (47) APIXABAN (41) ENOXAPARIN (34) ASPIRIN DL-LYSINE (33)

Which ABCIXIMAB Alternatives Have Lower Haemorrhagic transformation stroke Risk?

ABCIXIMAB vs ABEMACICLIB ABCIXIMAB vs ABILIFY ABCIXIMAB vs ABIRATERONE ABCIXIMAB vs ABIRATERONE\ABIRATERONE ABCIXIMAB vs ABOBOTULINUMTOXINA

Related Pages

ABCIXIMAB Full Profile All Haemorrhagic transformation stroke Reports All Drugs Causing Haemorrhagic transformation stroke ABCIXIMAB Demographics